100 episodes

Podcast by Talking Urology

Talking Urology Talking Urology

    • Science
    • 5.0, 8 Ratings

Podcast by Talking Urology

    So You’re Gonna … do a TURBT

    So You’re Gonna … do a TURBT

    So You’re Gonna . . . do a TURBT with Prof Lukas Lusuardi, Joseph Ischia & Nicholas Campbell.

    • 26 min
    ANZUP 2019 Interviews - Henry Woo chats to Kelly Parsons - clinician, clinical triallist and author

    ANZUP 2019 Interviews - Henry Woo chats to Kelly Parsons - clinician, clinical triallist and author

    In this ANZUP conference highlight, Henry Woo chats to Kelly Parsons Professor of Urology, UC San Diego. He is a clinician, a clinical triallist, and an author of wonderful and sometimes saucy medical fiction. Henry and Kelly explore the 5 key biases of urologists and surgeons, and why urologists need to get involved in clinical trial teams.

    • 10 min
    ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca

    ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca

    In this ANZUP conference highlight, Andrew Weickhardt chats with Betsy Plimack, Chief of the Division of Genitourinary Medical Oncology, Fox Chase Cancer Centre in the US. She talks about the future potential role of genetic mutations in urothelial cancer: can they predict response to treatments or even decide which treatments you should use? They also discuss the use of the new immuno-oncology agents in metastatic kidney cancer: what are the second line options, and how do we measure success of treatments- keep a close ear out for the emerging concept of treatment free survival as the yard stick for the immune-oncology agents.

    • 10 min
    ANZUP 2019 Interviews - Andrew Weickhardt talks with Ian Davis about the ENZAMET study

    ANZUP 2019 Interviews - Andrew Weickhardt talks with Ian Davis about the ENZAMET study

    In this ANZUP conference highlight, Andrew Weickhardt chats with Australia’s very own Ian Davis about ANZUP’s successful world leading phase 3 study, ENZAMET. Ian outlines ENZAMET for men with newly diagnosed metastatic hormone naïve prostate cancer and how it differs from the other trials involving second line anti-androgens in this space. Ian also discusses how you might decide between the myriad of treatment options that have now shown effect in the upfront hormone naïve metastatic setting.

    • 13 min
    ANZUP 2019 Interviews –Kath Schubach & Dr Catherine Paterson look at improving supportive care needs

    ANZUP 2019 Interviews –Kath Schubach & Dr Catherine Paterson look at improving supportive care needs

    In this ANZUP conference highlight, Kath Schubach chats to Catherine Paterson from the Department of Nursing and Midwifery, University of Canberra about some of the key messages from the nursing program at ANZUP how to improve the supportive care needs of patients with urological cancers.

    • 4 min
    ANZUP 2019 Interviews – Phuoc Tran, David Pryor & the Oriel trial for oligometastatic ca prostate

    ANZUP 2019 Interviews – Phuoc Tran, David Pryor & the Oriel trial for oligometastatic ca prostate

    In this ANZUP conference highlight, this year’s convenor David Pryor chats to Phuoc Tran, a radiation oncologist from John Hopkins, about his success with the Oriel trial of stereotactic radiation for patients with oligometastatic prostate cancer.

    • 5 min

Customer Reviews

5.0 out of 5
8 Ratings

8 Ratings

Hoppy Kanga ,

Great listening

Great work Joseph and Nathan, love the exploration of the literature and how to apply to patients.

Uro Fan ,

Science and wit

Important messages about the relevance of the latest literature delivered with great humour and credible experts

USANZ trainee ,

Excellent

Informative, up-to-date, funny podcasts from world leading urologists - what more could you ask for?

Top Podcasts In Science

Listeners Also Subscribed To